UA92423C2 - Антибактериальная композиция - Google Patents
Антибактериальная композицияInfo
- Publication number
- UA92423C2 UA92423C2 UAA200907781A UAA200907781A UA92423C2 UA 92423 C2 UA92423 C2 UA 92423C2 UA A200907781 A UAA200907781 A UA A200907781A UA A200907781 A UAA200907781 A UA A200907781A UA 92423 C2 UA92423 C2 UA 92423C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antibacterial composition
- fluoroquinolone
- diseases
- pasterellosis
- colibacteriosis
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 229940124307 fluoroquinolone Drugs 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010039438 Salmonella Infections Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 206010039447 salmonellosis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 abstract 1
- 229960001082 trimethoprim Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение относится к ветеринарной медицине, в частности, к препаратам, предназначенным для профилактики и лечения инфекционных заболеваний, например, сальмонеллеза, колибактериоза, пастереллеза и других заболеваний. Антибактериальная композиция содержит как минимум один фторхинолон или одну фармацевтически приемлемую соль фторхинолона, триметоприм, вспомогательные вещества, органическую кислоту и воду.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200907781A UA92423C2 (ru) | 2009-07-24 | 2009-07-24 | Антибактериальная композиция |
PCT/IB2009/054349 WO2011010190A1 (en) | 2009-07-24 | 2009-10-05 | Antibacterial composition comprising fluoroquinlone such as norfloxacin together with tripmethoprim |
EA200970881A EA017028B1 (ru) | 2009-07-24 | 2009-10-21 | Антибактериальная композиция |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200907781A UA92423C2 (ru) | 2009-07-24 | 2009-07-24 | Антибактериальная композиция |
Publications (1)
Publication Number | Publication Date |
---|---|
UA92423C2 true UA92423C2 (ru) | 2010-10-25 |
Family
ID=43498813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200907781A UA92423C2 (ru) | 2009-07-24 | 2009-07-24 | Антибактериальная композиция |
Country Status (3)
Country | Link |
---|---|
EA (1) | EA017028B1 (ru) |
UA (1) | UA92423C2 (ru) |
WO (1) | WO2011010190A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103341167B (zh) * | 2013-07-05 | 2015-03-18 | 成都乾坤动物药业有限公司 | 一种兽用复方醋酸溶液及其制备工艺 |
CN110237075A (zh) * | 2019-06-25 | 2019-09-17 | 华中农业大学 | 一种达氟沙星在治疗副猪嗜血杆菌药物中的用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4331147A1 (de) * | 1993-09-14 | 1995-03-16 | Nycomed Arzneimittel Gmbh | Intravenös verabreichbare, wäßrige Lösung |
ATE332692T1 (de) * | 1998-08-21 | 2006-08-15 | Kyorin Seiyaku Kk | Wässerige flüssige zubereitungen |
TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
RU2229884C2 (ru) * | 2002-03-04 | 2004-06-10 | Пятигорская государственная фармацевтическая академия | Способ стабилизации раствора ципрофлоксацина для инфузий |
CN1568997A (zh) * | 2003-07-04 | 2005-01-26 | 吕华冲 | 抗菌药物协同组合物 |
CA2666058A1 (en) * | 2006-10-12 | 2008-04-17 | Kyorin-Pharmaceutical Co., Ltd. | Aqueous liquid preparation comprising gatifloxacin |
CN100589807C (zh) * | 2007-04-28 | 2010-02-17 | 成青兰 | 一种复方磺胺间甲氧嘧啶钠注射液的配方及制作工艺 |
WO2009123098A1 (ja) * | 2008-03-31 | 2009-10-08 | 杏林製薬株式会社 | ガチフロキサシン含有水性液剤、その製造方法、および、該水性液剤の低温保存および凍結融解時の沈殿生成を抑制する方法 |
-
2009
- 2009-07-24 UA UAA200907781A patent/UA92423C2/ru unknown
- 2009-10-05 WO PCT/IB2009/054349 patent/WO2011010190A1/en active Application Filing
- 2009-10-21 EA EA200970881A patent/EA017028B1/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA017028B1 (ru) | 2012-09-28 |
EA200970881A1 (ru) | 2011-02-28 |
WO2011010190A1 (en) | 2011-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501306A1 (en) | Inhibitors of histone demethylases | |
EA033311B1 (ru) | Производные бензоксаборола в качестве антибактериальных средств | |
PH12015501964B1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
MX2013006040A (es) | Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis. | |
MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
EP2493464A4 (en) | METHYLSULFONYLMETHANE (MSM) FOR THE TREATMENT OF DRUG-RESISTANT MICROORGANISMS | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
IN2012DN01233A (ru) | ||
MX2015007556A (es) | Derivados de manosa para tratar infecciones bacterianas. | |
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
UA110199C2 (en) | Solid rifaximin dispersion | |
PH12015501609A1 (en) | Phenicol antibacterials | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
WO2012064897A3 (en) | Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use | |
MX367131B (es) | Sales de xantilio 3,6-disustituidas. | |
MX2011012614A (es) | Compuestos de quetolida que tienen actividad antimicrobiana. | |
WO2010042212A3 (en) | Methods for treating or preventing pain using spicamycin derivatives | |
IN2015DN02109A (ru) | ||
UA92423C2 (ru) | Антибактериальная композиция | |
MX2012004282A (es) | Composiciones farmaceuticas. | |
WO2010086617A3 (en) | Phosphoantigens for the treatment of burkholderia infections | |
UA94177C2 (en) | antimicrobial composition | |
MY182136A (en) | Pharmaceutical compositions | |
SA515360233B1 (ar) | مثبطات إنزيمات هستون ديميثيلاز |